Professor of Medicine, Sungkyunkwan University School of Medicine

Speciality Interests

Breast Cancer

Schedule

schedule of week
04 MON
22
TUE
23
WEN
24
THU
25
FRI
26
AM available available
PM available

Medical School

1999~2000 Ph.D. in Medicine KYUNGHEE UNIVERSITY GRADUATED SCHOOL, SEOUL, KOREA 1996~1998 Master of Science KYUNGHEE UNIVERSITY GRADUATED SCHOOL, SEOUL, KOREA 1987~1993 M.D. EWHA WOMEN'S UNIVERSITY COLLEGE OF MEDICINE, SEOUL, KOREA

Specialty Training

Specialty Training
Fellowship   1998~1999 DIVISION OF HEMATOLOGY AND ONCOLOGY, DEPARTMENT OF INTERNAL MEDICINE, KOREA CANCER CENTER HOSPITAL
Residency   1994~1998 INTERNAL MEDICINE, KOREA CANCER CENTER HOSPITAL
Internship   1993~1994 KOREA CANCER CENTER HOSPITAL

Other Education

  • 2021~Present Director Clinical trial center, Samsung Medical Center
    2017~2021 Director Breast Cancer Center, Samsung Medical Center
    2015~2017 Deputy Samsung Medical Center Cancer Hospital Planning Division
    2014~2015 Secretary Samsung Medical Center Cancer Hospital Breast Cancer Center
    2014~Present Professor DEPARTMENT OF HEMATOLOGY AND ONCOLOGY, SAMSUNG MEDICAL CENTER, SUNGKYUNKWAN UNIVERSITY, SCHOOL OF MEDICINE, SEOUL, KOREA
    2008~2014 Associate Professor DEPARTMENT OF HEMATOLOGY AND ONCOLOGY, SAMSUNG MEDICAL CENTER, SUNGKYUNKWAN UNIVERSITY, SCHOOL OF MEDICINE, SEOUL, KOREA
    2006~2007 POSTDOC FELLOWSHIP SYDNEY KIMMEL CANCER CENTER, SAN DIEGO, CA
    2006~2006 POSTDOC FELLOWSHIP UCSD CANCER CENTER, SAN DIEGO, CA
    2001~2006 STAFF DIVISION OF HEMATOLOGY AND ONCOLOGY, DEPARTMENT OF INTERNAL MEDICINE, KOREA CANCER CENTER HOSPITAL
    2000~2001 STAFF DIVISION OF HEMATOLOGY AND ONCOLOGY, DEPARTMENT OF INTERNAL MEDICINE, SEOUL ADVENTIST HOSPITAL

Participation in Academic Societies
and Research

  • Present Member AMERICAN SOCIETY OF CLINICAL ONCOLOGY
    Present Member AMERICAN ASSOCIATION FOR CANCER RESEARCH
    Present Member THE KOREAN MEDICAL ASSOCIATION
    Present Member THE KOREAN ASSOCIATION OF INTERNAL MEDICINE
    Present Member THE KOREAN CANCER ASSOCIATION
    Present Member EUROPEAN SOCIETY OF MEDICAL ONCOLOGY
    Present Member KOREAN SOCIETY OF MEDICAL ONCOLOGY

Thesis

ONCOLOGIST 2021 10.1002/onco.13833

Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3

Rugo1, HS; Cristofanilli, M; Loibl, S; Harbeck, N; DeMichele, A; Iwata, H; Park, YH; Brufsky, A; Theall, KP; Huang, X; McRoy, L; Bananis, E; Turner, NC

CYTOKINE 2021 10.1016/j.cyto.2021.155487

Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)

Kim1, JW; Lee, S; Kim, HS; Choi, YJ; Yoo, J; Park, KU; Kang, SY; Park, YH; Jung, KH; Ahn, JH; Oh, HS; Choi, IS; Kim, HJ; Lee, KH; Lee, S; Seo, JH; Park, IH; Lee, KE; Kim, HY; Park, KH

FRONT ONCOL 2021 10.3389/fonc.2021.596364

Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry

Kim1, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH

LANCET ONCOL 2021

Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study

Rugo1, HS; Lerebours, F; Ciruelos, E; Drullinsky, P; Ruiz-Borrego, M; Neven, P; Park, YH; Prat, A; Bachelot, T; Juric, D; Turner, N; Sophos, N; Zarate, JP; Arce, C; Shen, YM; Turner, S; Kanakamedala, H; Hsu, WC; Chia, S

FRONT ONCOL 2021 10.3389/fonc.2021.653243

The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study

Lee1, K; Sim, SH; Kang, EJ; Seo, JH; Chae, H; Lee, KS; Kim, JY; Ahn, JS; Im, YH; Park, S; Park, YH; Park, IH

CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

2. Right to be informed and to make an autonomous decision

Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

3. Right to confidentiality

Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

4. Right to request consultation and mediation

In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

5. Right to have values and beliefs respected

Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

6. Right to receive care in a safe setting

Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

Patients' Responsibilities

1. Responsibility to trust and respect the medical team

Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

2. Responsibility to not use dishonest methods for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

3. Responsibility to abide by all hospital regulations

Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.